Hematology and Oncology Studies

PPD’s hematology and oncology team shares your commitment in the fight against cancer. Our knowledge of hematology and oncology research, our vast capabilities and our experience with feasibility studies can significantly impact study efficiency and success. In the last five years, we conducted or supported more than 350 hematology/oncology protocols with over 80,000 patients.

Scientific and Medical Expertise

Our hematology and oncology experts across the globe ensure your trials stay on track at any phase of development, from discovery to late stage research. Our team includes:

• More than 3,000 staff worldwide with experience in hematology and oncology
• A senior medical director who provides critical scientific oversight with more than a decade of drug discovery and development expertise. He is board certified in internal medicine, hematology and medical oncology
• An international oncology advisory board that offers PPD clients valuable clinical insight and drug development consulting

Global Hematology and Oncology Investigator Network

Timely clinical trial startups count in the race against cancer. Our global network consists of nearly 10,000 investigators with hematology and oncology experience, and we have close relationships and consulting agreements with physicians at most of the major tertiary and academic cancer centers. The network enables PPD to start and move quickly.

Hematology and Oncology Therapeutic Services

From individual clinical trials to the whole life cycle of your compound, let us help you with a strategy at any stage of development. We offer development-focused therapeutic experience from preclinical investigation through post-approval reporting:

• Investigator-initiated research protocols conducted in large cancer centers and local practices, including investigational new drug (IND) exempt and nonexempt trials:
• • Non-small cell lung cancer
  • Prostate cancer
  • Breast cancer
  • Ovarian cancer
• Therapeutic safety profiles focused on specific cellular targets that facilitate accelerated access to the market
• Late stage research capabilities, including:
• • Phase IIIb-IV studies
  • Safety surveillance studies
  • Pharmacoepidemiology
  • Risk management
  • Observational studies
  • Registries

Medical Imaging Services

PPD expedites clients’ oncology clinical trials with best-in-class, comprehensive clinical development and medical imaging services. This unique offering provides:

• A strategically integrated approach that allows clients to benefit from efficiencies and make fast, confident decisions
• Tailored solutions designed to meet the unique needs of each client's oncology development program and quickly progress their therapies from early phase to regulatory approval
• Seamless integration of technologies and processes, giving biopharmaceutical companies near real-time, consistent and reliable medical imaging information to expedite their drug development programs

Learn more about PPD’s medical imaging services and its strategic alliance with VirtualScopics.